Martha Franco

4.1k total citations
105 papers, 3.4k citations indexed

About

Martha Franco is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Martha Franco has authored 105 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 28 papers in Molecular Biology and 28 papers in Physiology. Recurrent topics in Martha Franco's work include Nitric Oxide and Endothelin Effects (20 papers), Hormonal Regulation and Hypertension (16 papers) and Renin-Angiotensin System Studies (12 papers). Martha Franco is often cited by papers focused on Nitric Oxide and Endothelin Effects (20 papers), Hormonal Regulation and Hypertension (16 papers) and Renin-Angiotensin System Studies (12 papers). Martha Franco collaborates with scholars based in Mexico, United States and Brazil. Martha Franco's co-authors include Edilia Tapia, Richard J. Johnson, Laura Gabriela Sánchez‐Lozada, Carmen Ávila-Casado, Bernardo Rodríguez‐Iturbe, Virgilia Soto, Takahiko Nakagawa, Jaime Herrera-Acosta, José Santamaría and Rocí­o Bautista and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Martha Franco

104 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha Franco Mexico 30 1.2k 994 832 710 625 105 3.4k
Yoon Sik Chang South Korea 37 951 0.8× 538 0.5× 1.1k 1.3× 464 0.7× 607 1.0× 94 3.8k
Keiji Isshiki Japan 38 1.4k 1.1× 1.1k 1.1× 1.7k 2.1× 326 0.5× 593 0.9× 73 5.1k
Kei Fukami Japan 35 1.0k 0.8× 1.3k 1.3× 1.0k 1.2× 434 0.6× 378 0.6× 135 4.5k
Shu Wakino Japan 41 1.2k 1.0× 1.3k 1.3× 2.6k 3.2× 697 1.0× 853 1.4× 171 6.3k
Masami Chin‒Kanasaki Japan 26 878 0.7× 716 0.7× 993 1.2× 216 0.3× 556 0.9× 45 3.2k
Virgilia Soto Mexico 24 1.6k 1.3× 630 0.6× 706 0.8× 902 1.3× 569 0.9× 36 3.0k
Lorenzo A. Calò Italy 34 731 0.6× 875 0.9× 1.5k 1.8× 293 0.4× 515 0.8× 234 4.2k
Songming Huang China 36 1.2k 1.0× 357 0.4× 1.9k 2.3× 545 0.8× 458 0.7× 183 4.3k
Takashi Uzu Japan 42 1.6k 1.3× 1.5k 1.5× 1.6k 1.9× 329 0.5× 1.0k 1.7× 153 6.7k
Terri J. Allen Australia 48 1.9k 1.6× 2.0k 2.0× 1.5k 1.8× 362 0.5× 724 1.2× 112 6.2k

Countries citing papers authored by Martha Franco

Since Specialization
Citations

This map shows the geographic impact of Martha Franco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Franco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Franco more than expected).

Fields of papers citing papers by Martha Franco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Franco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Franco. The network helps show where Martha Franco may publish in the future.

Co-authorship network of co-authors of Martha Franco

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Franco. A scholar is included among the top collaborators of Martha Franco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Franco. Martha Franco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Franco, Martha, et al.. (2024). SARS-CoV-2 Spike Protein Enhances Carboxypeptidase Activity of Angiotensin-Converting Enzyme 2. International Journal of Molecular Sciences. 25(11). 6276–6276. 1 indexed citations
3.
4.
Franco, Martha, et al.. (2023). Metabolismo de los esfingolípidos y su relación con las enfermedades cardiovasculares, renales y metabólicas. SHILAP Revista de lepidopterología. 93(1). 88–95. 5 indexed citations
5.
Franco, Martha, Agustina Cano-Martı́nez, María del Pilar Ramos‐Godínez, et al.. (2023). Immunolocalization of Sphingolipid Catabolism Enzymes along the Nephron: Novel Early Urinary Biomarkers of Renal Damage. International Journal of Molecular Sciences. 24(23). 16633–16633. 3 indexed citations
6.
Tasanarong, Adis, et al.. (2023). Interaction of Angiotensin II AT1 Receptors with Purinergic P2X Receptors in Regulating Renal Afferent Arterioles in Angiotensin II-Dependent Hypertension. International Journal of Molecular Sciences. 24(14). 11413–11413. 4 indexed citations
7.
Franco, Martha, et al.. (2022). Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats. International Journal of Molecular Sciences. 23(5). 2883–2883. 14 indexed citations
8.
Satou, Ryousuke, Martha Franco, Courtney Dugas, Akemi Katsurada, & L. Gabriel Navar. (2022). Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension. International Journal of Molecular Sciences. 23(14). 7680–7680. 5 indexed citations
9.
Bautista‐Pérez, Rocío, Óscar Pérez‐Méndez, Agustina Cano-Martı́nez, et al.. (2020). The Role of P2X7 Purinergic Receptors in the Renal Inflammation Associated with Angiotensin II-Induced Hypertension. International Journal of Molecular Sciences. 21(11). 4041–4041. 18 indexed citations
10.
Shao, Weijian, et al.. (2020). Purinergic P2X1receptor, purinergic P2X7receptor, and angiotensin II type 1 receptor interactions in the regulation of renal afferent arterioles in angiotensin II-dependent hypertension. American Journal of Physiology-Renal Physiology. 318(6). F1400–F1408. 8 indexed citations
12.
13.
Carreón‐Torres, Elizabeth, Sara Frı́as, Marco Antonio Juárez-Oropeza, et al.. (2019). Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits. International Journal of Molecular Sciences. 20(10). 2521–2521. 6 indexed citations
14.
Buelna‐Chontal, Mabel, Martha Franco, Luz Hernández‐Esquivel, et al.. (2017). CDP‐choline circumvents mercury‐induced mitochondrial damage and renal dysfunction. Cell Biology International. 41(12). 1356–1366. 5 indexed citations
15.
Franco, Martha, Rocío Bautista‐Pérez, Agustina Cano-Martı́nez, et al.. (2017). Physiopathological implications of P2X1and P2X7receptors in regulation of glomerular hemodynamics in angiotensin II-induced hypertension. American Journal of Physiology-Renal Physiology. 313(1). F9–F19. 24 indexed citations
16.
Osorio‐Alonso, Horacio, et al.. (2012). Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats. Diabetes Research and Clinical Practice. 97(2). 276–282. 27 indexed citations
17.
Rosas, Martı́n, Gustavo Pastelı́n, Gilberto Vargas‐Alarcón, et al.. (2008). Guías clínicas para la detección, prevención, diagnóstico y tratamiento de hipertensión arterial sistémica en México (2008). Revista Portuguesa de Pneumologia. 78. 5–57. 3 indexed citations
18.
Mariani, Erminia, et al.. (1998). Inhaled Steroids and Adrenal Function in Asthmatic Children. Pediatric Asthma Allergy & Immunology. 12(2). 117–121. 1 indexed citations
19.
Bobadilla, Norma A., Edilia Tapia, Martha Franco, et al.. (1994). Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity. Kidney International. 46(3). 773–779. 73 indexed citations
20.
Herrera-Acosta, Jaime, Martha Franco, Edilia Tapia, et al.. (1986). Mechanism of glomerular permeability reduction in nonclipped kidney of rats with goldblatt hypertension. Hypertension. 8(4). 105–109. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026